These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2342629)

  • 1. Functional heterogeneity of Sarcoma I cells in transplantation experiments.
    Sobotková E; Sůla K; Nouza K
    Neoplasma; 1990; 37(2):139-47. PubMed ID: 2342629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppression versus immunity in syngeneic and allogeneic tumours.
    Vlachov K; Nouza K
    Neoplasma; 1973; 20(1):3-12. PubMed ID: 4573871
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of destructive mechanisms of the immune response to sarcoma I allograft in mice.
    Vidrnová M; Nouza K; Nĕmec M
    Neoplasma; 1984; 31(4):369-80. PubMed ID: 6472512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of anti-Thy-1.2 monoclonal antibody and xenogeneic antithymocyte serum on the development of SaI tumor allograft in mice.
    Sobotková E; Sůla K; Nouza K
    Neoplasma; 1988; 35(4):361-7. PubMed ID: 3263580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune response of mice to sarcoma I allograft studied by adoptive transfers of spleen, thymus, and lymph node cells to secondary recipients.
    Vidrnová M; Nouza K; Panajotovová V
    Neoplasma; 1985; 32(4):451-61. PubMed ID: 4047256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of allogeneic tumor transplants: induced rejection of advanced tumors by immune alteration of recipients.
    Russell PS; Chase CM; Burton RC
    J Immunol; 1983 Feb; 130(2):951-7. PubMed ID: 6336775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory role of T lymphocytes and NK cells in tumor allograft development.
    Sobotková E; Nouza K
    Neoplasma; 1993; 40(2):75-80. PubMed ID: 8350958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of immunosuppression on the induction and immunogenicity of chemically induced sarcomas.
    Fisher JC; Davis RC; Mannick JA
    Surgery; 1970 Jul; 68(1):150-6; discussion 156-7. PubMed ID: 10483462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment.
    Yoshida R; Yoneda Y; Kuriyama M; Kubota T
    J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of immunosuppression on survival and growth of cartilage produced by transplanted allogeneic epiphyseal chondrocytes.
    Malejczyk J; Moskalewski S
    Clin Orthop Relat Res; 1988 Jul; (232):292-303. PubMed ID: 3383495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of immunosuppression on rejection of cartilage formed by transplanted allogeneic rib chondrocytes in mice.
    Malejczyk J; Osiecka A; Hyc A; Moskalewski S
    Clin Orthop Relat Res; 1991 Aug; (269):266-73. PubMed ID: 1864049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of cyclophosphamide and irradiation singly and in combination upon SaI growth in A/J mice.
    Anderson RE; Williams WL; Tokuda S
    Am J Pathol; 1987 May; 127(2):373-9. PubMed ID: 3555105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory role of macrophages in tumor allograft development.
    Vidrnová M; Nouza K; Sůla K
    Neoplasma; 1985; 32(1):3-8. PubMed ID: 2984591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Distribution and elimination of transplanted sarcoma JWS and leukemia L1210 cells in allogeneic recipients--inbred C57BL mice by intravenous route].
    Skierska E; Skierski JS
    Med Dosw Mikrobiol; 1991; 43(3-4):161-5. PubMed ID: 1823379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic hybridization and oncogenesis; (Mechanism of formation of malignant tumors and metastases by the action of antilymphocytic serum).
    Mekler LB; Artamonova SI; Bodyagin DA; Drize OB; Mkheidze DM; Osechinskii IV; Solenov VN
    Sov J Dev Biol; 1975 May; 5(3):201-19. PubMed ID: 164699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of target antigens coded by subregions of the mouse H-2 complex in the nature of growth of sarcoma I tumor allograft.
    Vidrnová M; Nouza K
    Neoplasma; 1983; 30(5):527-32. PubMed ID: 6606786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma.
    Parrott NR; Lennard TW; Proud G; Shenton BK; Givan A; White MD; Taylor R
    Ann R Coll Surg Engl; 1990 Mar; 72(2):77-81. PubMed ID: 2334101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitating cells enable engraftment of purified fetal liver stem cells in allogeneic recipients.
    Gaines BA; Colson YL; Kaufman CL; Ildstad S
    Exp Hematol; 1996 Jul; 24(8):902-13. PubMed ID: 8690049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of the tumoral growth induced by the injection of histo-incompatible cells producing interleukin-2].
    Roth C; Mir LM; Cressent M; Quintin-Colonna F; Belehradek J; Ley V; Fradelizi D; Kourilsky P
    C R Acad Sci III; 1992; 314(11):499-504. PubMed ID: 1521169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.